Vertex Pharmaceuticals
VRTX
#175
Rank
NZ$202.14 B
Marketcap
NZ$788.44
Share price
-0.41%
Change (1 day)
0.84%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$29.97 Billion

According to Vertex Pharmaceuticals's latest financial reports the company has NZ$29.97 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Vertex Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$29.09 B4.67%
2023-12-31$NZ$27.79 B26.86%
2022-12-31$NZ$21.91 B48.19%
2021-12-31$NZ$14.78 B22.82%
2020-12-31$NZ$12.03 B33.24%
2019-12-31$NZ$9.03 B36.65%
2018-12-31$NZ$6.61 B129.93%
2017-12-31$NZ$2.87 B48.85%
2016-12-31$NZ$1.93 B20.9%
2015-12-31$NZ$1.59 B14.21%
2014-12-31$NZ$1.39 B-15.24%
2013-12-31$NZ$1.65 B13.55%
2012-12-31$NZ$1.45 B22.19%
2011-12-31$NZ$1.18 B82.11%
2010-12-31$NZ$0.65 B-56.72%
2009-12-31$NZ$1.50 B266.7%
2008-12-31$NZ$0.41 B16.22%
2007-12-31$NZ$0.35 B-50.68%
2006-12-31$NZ$0.71 B105.23%
2005-12-31$NZ$0.34 B604.53%
2004-12-31$NZ$49.66 M-83.26%
2003-12-31$NZ$0.29 B-58.99%
2002-12-31$NZ$0.72 B-36.81%
2001-12-31$NZ$1.14 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
NZ$37.14 B 23.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-NZ$4.5 Billion-115.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$89.85 B 199.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$32.19 B 7.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$137.22 B 357.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
NZ$0.13 B-99.54%๐Ÿ‡บ๐Ÿ‡ธ USA